Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3275729 | Médecine des Maladies Métaboliques | 2011 | 5 Pages |
Abstract
But a reduced statistical power due to the fact that the event rate observed in the standard-therapy group was almost 50% lower than the expected rate complicated the interpretation of the results. And this trial does not answer to the question whether a SBP <130Â mmHg is better than <140Â mmHg. Nevertheless, it can be suggested to modulate the BP goal according to the degree of cardiovascular risk and SBP <120Â mmHg should be avoided when cardiovascular risk is high.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
B. Bouhanick, F. Ah-Kang, B. Chamontin,